Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
23.24
-0.01 (-0.04%)
Aug 28, 2025, 9:45 AM CST
-0.04%
Market Cap12.61B
Revenue (ttm)3.28B
Net Income (ttm)-90.66M
Shares Out542.18M
EPS (ttm)-0.17
PE Ration/a
Forward PE174.38
Dividendn/a
Ex-Dividend Daten/a
Volume2,868,400
Average Volume27,623,686
Open23.00
Previous Close23.25
Day's Range23.00 - 23.50
52-Week Range10.91 - 26.25
Beta0.64
RSI54.46
Earnings DateAug 23, 2025

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. The company operates in China and internationally. The company was formerly known as Porton Fine Ch... [Read more]

Sector Healthcare
Founded 2005
Employees 4,214
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.